A Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination With Chemotherapy or Toripalimab in Advanced Solid Tumors

NCT05173142 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: HMPL-453
DRUG: gemcitabine and cisplatin
DRUG: toripalimab
DRUG: Docetaxel

Sponsor

Hutchison Medipharma Limited